LUMOS PHARMA, INC. reports

Company location: Austin, TX
Fiscal year end: 31 December

LUMOS PHARMA, INC. has filed 1,020 SEC EDGAR filings since 07 Feb 2002

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 701-725 of 1,000 matching filings.

Per page

25

Current page

29

4

FORM 4

Filing date: 06 Jan 2015
Reporting date: 02 Jan 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 06 Jan 2015
Reporting date: 02 Jan 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 06 Jan 2015
Reporting date: 02 Jan 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35342

8-K

Filing date: 06 Jan 2015
Reporting date: 06 Jan 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35342

8-K

Filing date: 22 Dec 2014
Reporting date: 22 Dec 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

CT ORDER File 001-35342

CT ORDER filing

Filing date: 09 Dec 2014
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 05 Dec 2014
Reporting date: 03 Dec 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 25 Nov 2014
Reporting date: 25 Nov 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35342

8-K

Filing date: 24 Nov 2014
Reporting date: 24 Nov 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35342

8-K

Filing date: 17 Nov 2014
Reporting date: 17 Nov 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35342

8-K

Filing date: 14 Nov 2014
Reporting date: 14 Nov 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 12 Nov 2014
Reporting date: 07 Nov 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-35342

10-Q

Filing date: 10 Nov 2014
Reporting date: 30 Sep 2014
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-35342

Q3-2014 FORM 8-K

Filing date: 06 Nov 2014
Reporting date: 06 Nov 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 28 Oct 2014
Reporting date: 24 Oct 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 Oct 2014
Reporting date: 22 Oct 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 Oct 2014
Reporting date: 22 Oct 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 20 Oct 2014
Reporting date: 16 Oct 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35342

NEWLINK - GENENTECH COLLABORATION AGREEMENT

Filing date: 20 Oct 2014
Reporting date: 20 Oct 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 14 Oct 2014
Reporting date: 11 Oct 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 07 Oct 2014
Reporting date: 03 Oct 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Oct 2014
Reporting date: 01 Oct 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Oct 2014
Reporting date: 01 Oct 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 03 Oct 2014
Reporting date: 01 Oct 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35342

8-K

Filing date: 01 Oct 2014
Reporting date: 01 Oct 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .